Control of post-prandial hyperglycemia - An essential part of good diabetes treatment and prevention of cardiovascular complications

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 12, Issue 2, 2002, Pages 98-107

  Hanefeld, M ^a   Temelkova Kurktschiev, T ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cardiovascular complications; Hyperglycemia; Post prandial glucose; Prandial oral antidiabetic drugs; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; METABOLISM; MORTALITY; POSTPRANDIAL STATE; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MORTALITY; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 0036527872     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Panzram G, Zabel-Langhennig R (1981) Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20: 587-591
2. Pyörälä K, Epstein FH, Kornitzer M (1985) Changing trends in coronary heart disease mortality; possible explanations. Cardiology 72: 5-10
3. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583
4. Schneider H, Lischinski M, Jutzi E (1993) Survival time after onset of diabetes: 29-year follow-up mortality study in a diabetes cohort from a rural district. Diabetes Metab 19: 152-158
5. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J (1997) Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care 20: 163-169
6. The DECODE study group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621
7. Zimmet P, Serjeantson S (1992) The epidemiology of diabetes mellitus and its relationship with cardiovascular disease. In: Lefébvre PJ, Standl E (eds) New aspects in diabetes. Walter de Gruyter, Berlin, New York, pp 5-21
8. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444
9. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M (1988) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234
10. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
11. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968-983
12. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
13. McCormack J, Greenhalgh T (2000) Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom Prospective Diabetes Study. BMJ 320: 1720-1723
14. Nathan DM (1998) Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study. Lancet 352: 832-833
15. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865
16. Gerstein HC (1998) Dysglycaemia: a cardiovascular risk factor. Diabetes Res Clin Pract 40 (Suppl): S9-S14
17. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study. (UKPDS: 23) BMJ 316: 823-828
18. Hall PM, Cook JG, Sheldon J, Rutherford SM, Gould BJ (1984) Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance. Diabetes Care 7: 147-150
19. Haller H (1997) Postprandial glucose and vascular disease. Diabet Med 14 (Suppl 3): S50-S56
20. Avignon A, Radauceanu A, Monnier L (1997) Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20: 1822-1826
21. Monnier L (2000) Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Eur J Clin Invest 30 (Suppl 2): 3-11
22. Del Prato S (2001) Pathophysiology of the post-prandial disease: impact of post-prandial hyperglycemia. In: Hanefeld M, Julius U (Hrsg) Das Metabolische Syndrom 2000 - eine postprandiale Krankheit? Urban & Foscher Verlag München, Jena, pp 33-42
23. Lefebvre PJ, Scheen AJ (1999) Glucose metabolism and the postprandial state. Eur J Clin Invest 29 (Suppl 2): 1-6
24. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dünn JK, Gotto AM Jr, Patsch W (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12: 1336-1345
25. Ceriello A (1997) Acute hyperglycaemia and oxidative stress generation. Diabet Med 14: S45-S49
26. Buse JB, Hroscikoski M (1998) The case for a role for postprandial glucose monitoring in diabetes management. J Fam Pract 47 (Suppl 5): S29-S36
27. Bouma M, Dekker JH, de Sonnaville JJ, van der Does FE, de Vries H, Kriegsman DM, Kostense PJ, Heine RJ, van Eijk JT (1999) How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 22: 904-907
28. Hanefeld M, Temelkova-Kurktschiev T (1999) Der postprandiale Status - eine kritische Phase der Stoffwechselregulation bei Diabetes: Konsequenzen für das Gefäßrisiko. Diabetes Stoffwechsel 8 (Suppl 6): 3-7
29. Temelkova-Kurktschiev T, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M (2000) Post-challenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose and glycosylated hemoglobin level. Diabetes Care 23: 1830-1834
30. Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW (1988) Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 37: 736-744
31. Kosaka K, Hagura R, Kuzuya T (1977) Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26: 944-952
32. Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D Jr (1984) Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 7: 491-502
33. Bruttomesso D (1999) Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 48:99-105
34. Chiasson JL, Josse RG, Leiter LA (1996) The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care 19: 1190-1193
35. Laube H, Linn T, Heyen P (1998) The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance. Exp Clin Endocrinol Diabetes 106: 231-233
36. Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D (2000) Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care 23: 1162-1167
37. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T (1999) Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144: 229-235
38. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K, Siegert G, Hanefeld M (1998) Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 41: 706-712
39. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C (1999) Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16: 212-218
40. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, Hanefeld M (1999) Increased intimal-medial thickness in newly detected type 2 diabetes. Risk factors. Diabetes Care 22: 333-338
41. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E., Hahnefeld A, Fücker K, Siegert G, Hanefeld M, (1998) Beziehungen zwischen verschiedenen Stadien der Glukosetoleranz, etablierten Risikofaktoren für Arteriosklerose und Intima-Media-Dicke (IMD) der A. carotis communis. Diabetes Stoffwechsel 7: 227-232
42. Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T (2000) Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med 17: 835-840
43. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E (1998) High blood glucose concentration is a risk factor for mortality in middle aged nondiabetic men. Diabetes Care 21: 360-367
44. Jarrett RJ (1996) The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 13: 15-19
45. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263: 2893-2898
46. Home PD (2000) Postprandial hyperglycaemia: mechanisms and importance. Diabetes Obes Metab 2 (Suppl 1): S7-S11
47. Groeneveld Y, Petri H, Hermans J, Springer MP (1999) Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 16: 2-13
48. Donahue RP, Abbott RD, Reed DM, Yano K (1987) Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu heart program. Diabetes 36: 689-692
49. Vaccaro O, Ruth KJ, Stamler J (1992) Relationship of postload plasma glucose to mortality with 19-yr follow-up. Comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study. Diabetes Care 15: 1328-1334
50. The DECODE Study Group, the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161: 397-405
51. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-967
52. Barrett-Connor E, Ferrara A (1998) Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo study. Diabetes Care 21: 1236-1239
53. Hanefeld M, Temelkova-Kurktschiev T (1997) The postprandial state and the risk of atherosclerosis. Diabet Med 14 (Suppl 3): S6-S11
54. Qiao Q, de Vegt F, Nijpels G, Everhard F, Nissinen A, Tuomilehto J, Dekker JM, Heine RJ (2000) 2h blood glucose is a better predictor for all cause mortality than either HbA1c or fasting plasma glucose. Abstract book of the 17th International Diabetes Federation Congress, November 5-10, Mexico City, Mexico, p 533
55. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M (1998) The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care 21: 1720-1725